A quinazoline derivative that inhibits EPIDERMAL GROWTH FACTOR RECEPTOR and HER2 (ERB-B2 RECEPTOR TYROSINE KINASES) tyrosine kinases. It is used for the treatment of advanced or metastatic breast cancer, where tumors overexpress HER2.
Phase 3 trials (5)
Phase 2 trials (8)